berger-sweeney_joanne
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | |||
| berger-sweeney_joanne [2024/08/30 17:50] – bant06 | berger-sweeney_joanne [2025/10/02 14:37] (current) – bant06 | ||
|---|---|---|---|
| Line 4: | Line 4: | ||
| [{{:: | [{{:: | ||
| - | Joanne Berger-Sweeney | + | Joanne Berger-Sweeney |
| Berger-Sweeney received her undergraduate degree in psychobiology from Wellesley College and her M.P.H. in environmental health sciences from the University of California, Berkeley. While working on her Ph.D. in neurotoxicology from the Johns Hopkins School of Public Health, Berger-Sweeney did the proof of concept work on Razadyne, which went on to be the second-most-used Alzheimer’s drug in the world. She completed her postdoctoral training at the National Institute of Health (INSERM) in Paris, France. | Berger-Sweeney received her undergraduate degree in psychobiology from Wellesley College and her M.P.H. in environmental health sciences from the University of California, Berkeley. While working on her Ph.D. in neurotoxicology from the Johns Hopkins School of Public Health, Berger-Sweeney did the proof of concept work on Razadyne, which went on to be the second-most-used Alzheimer’s drug in the world. She completed her postdoctoral training at the National Institute of Health (INSERM) in Paris, France. | ||
berger-sweeney_joanne.txt · Last modified: by bant06
